VCA
Verdence Capital Advisors’s AstraZeneca AZN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.81M | Buy |
40,283
+982
| +2% | +$68.6K | 0.19% | 119 |
|
2025
Q1 | $2.89M | Buy |
39,301
+6,793
| +21% | +$499K | 0.22% | 110 |
|
2024
Q4 | $2.13M | Buy |
32,508
+3,007
| +10% | +$197K | 0.17% | 150 |
|
2024
Q3 | $2.3M | Buy |
29,501
+2,020
| +7% | +$157K | 0.18% | 143 |
|
2024
Q2 | $2.14M | Buy |
27,481
+10,137
| +58% | +$791K | 0.19% | 138 |
|
2024
Q1 | $1.18M | Buy |
17,344
+872
| +5% | +$59.1K | 0.11% | 216 |
|
2023
Q4 | $1.11M | Sell |
16,472
-1,098
| -6% | -$74K | 0.11% | 205 |
|
2023
Q3 | $1.19M | Buy |
17,570
+1,080
| +7% | +$73.1K | 0.13% | 183 |
|
2023
Q2 | $1.18M | Sell |
16,490
-2,033
| -11% | -$146K | 0.14% | 172 |
|
2023
Q1 | $1.29M | Sell |
18,523
-194
| -1% | -$13.5K | 0.16% | 159 |
|
2022
Q4 | $1.27M | Buy |
18,717
+1,281
| +7% | +$86.9K | 0.16% | 144 |
|
2022
Q3 | $956K | Buy |
17,436
+757
| +5% | +$41.5K | 0.13% | 173 |
|
2022
Q2 | $1.1M | Buy |
16,679
+2,796
| +20% | +$185K | 0.14% | 165 |
|
2022
Q1 | $921K | Buy |
13,883
+106
| +0.8% | +$7.03K | 0.1% | 208 |
|
2021
Q4 | $803K | Buy |
13,777
+1,610
| +13% | +$93.8K | 0.09% | 205 |
|
2021
Q3 | $731K | Buy |
12,167
+1,830
| +18% | +$110K | 0.1% | 214 |
|
2021
Q2 | $619K | Sell |
10,337
-74
| -0.7% | -$4.43K | 0.09% | 231 |
|
2021
Q1 | $518K | Buy |
10,411
+4,274
| +70% | +$213K | 0.09% | 218 |
|
2020
Q4 | $307K | Buy |
+6,137
| New | +$307K | 0.06% | 284 |
|
2019
Q1 | – | Sell |
-14,763
| Closed | -$561K | – | 271 |
|
2018
Q4 | $561K | Sell |
14,763
-4,508
| -23% | -$171K | 0.16% | 137 |
|
2018
Q3 | $763K | Sell |
19,271
-13,134
| -41% | -$520K | 0.19% | 120 |
|
2018
Q2 | $1.14M | Sell |
32,405
-4,492
| -12% | -$158K | 0.28% | 86 |
|
2018
Q1 | $1.29M | Sell |
36,897
-1,749
| -5% | -$61.1K | 0.31% | 76 |
|
2017
Q4 | $1.34M | Buy |
+38,646
| New | +$1.34M | 0.32% | 66 |
|